A new study shows that common doses of glucosamine, which some people use to treat arthritis-like symptoms, do not boost levels of HDL cholesterol in diabetes patients as suggested by previous research.
Published in Brief:
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan